Latest autoimmune diseases Stories
NEW YORK, Feb.
NEW YORK, Feb. 2, 2015 /PRNewswire-USNewswire/ -- The number of inflammatory bowel disease (IBD) patients in the U.S.
SANTA BARBARA, Calif., Jan. 29, 2015 /PRNewswire/ -- VG Life Sciences, (VGLS), a biotechnology company developing therapies for autoimmune and infectious diseases, today announced the U.S.
- 90% of subjects had reduction of free IgE to below the limit of detection by the end of XmAb7195 infusion, including at lowest dose evaluated of 0.3 mg/kg - MONROVIA, Calif.,
LONDON, January 22, 2015 /PRNewswire/ -- Report Details Treating Crohn's disease and ulcerative colitis - how to find R&D trends, opportunities and revenue
NEW YORK, Jan.
SGM-1019 is an oral small molecule inhibitor of a target identified by company's Microbiome Discovery Platform SOUTH SAN FRANCISCO, Jan.
- Trial results show novel S1P1 modulator produced strong, dose-dependent lymphocyte lowering - SAN DIEGO, Jan. 7, 2015 /PRNewswire/ -- Arena Pharmaceuticals, Inc.
Findings supporting novel approaches to inhibit or enhance immune responses for treating autoimmunity and cancer published in Nature Chemical Biology. ANN ARBOR, Mich., Jan.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.